5-(PYRIMIDIN-4-YL)-2-(PYRROLIDIN-1-YL)NICOTINONITRILE COMPOUNDS AS IKKE, TBK1 AND/OR SIK2 KINASES INHIBITORS
![Thumbnail](/bitstream/handle/internal/3985/WO2018154315A1_Original_document_20200819114542.pdf.jpg?sequence=14&isAllowed=y)
View/ Open
Date
2018-08-30ICR Author
Author
Newton, G
Stewart, M
Type
Patent
Metadata
Show full item recordAbstract
The invention provides compounds of formula (I) wherein R is −CH3 or −CH2CH3 and pharmaceutically acceptable salts thereof. The compounds of formula (I) are useful in the treatment of diseases or disorders mediated by IKKE, TBK1 and/or SIK2 mechanisms in a subject, for example cancer and inflammatory and tissue repair disorders. The invention also provides uses of the compounds of formula (I) and compositions containing them. (Formula (I))
Collections
Subject
Kinase
Inflammation
Cancer
Research team
Medicinal Chemistry 3
Language
eng
License start date
2018-08-30
Citation
2018